natgillin/translations-raw huggingface dataset:
In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where the Commission will adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission will set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later.
S obzirom na cilj članka 17. prvog stavka Uredbe (EZ) br. 1107/2009, u slučajevima kada Komisija donese uredbu kojom se predviđa da se odobrenje aktivne tvari iz Priloga toj Uredbi ne obnavlja jer nisu ispunjeni uvjeti za izdavanje odobrenja, Komisija kao datum prestanka valjanosti određuje isti datum koji je vrijedio prije donošenja ove Uredbe ili datum stupanja na snagu uredbe kojom se predviđa da se odobrenje aktivne tvari ne obnavlja, ovisno o tome koji je datum kasniji.
Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).
Provedbena uredba Komisije (EU) br. 844/2012 od 18. rujna 2012. o utvrđivanju odredbi potrebnih za provedbu postupka obnove odobrenja aktivnih tvari, kako je predviđeno Uredbom (EZ) br. 1107/2009 Europskog parlamenta i Vijeća o stavljanju na tržište sredstava za zaštitu bilja (SL L 252, 19.9.2012., str. 26.).
in the sixth column, expiration of approval, of row 141, fenamiphos, the date of ‘31 July 2017’ is replaced by ‘31 July 2018’;
U šestom stupcu, prestanak odobrenja, retka 141., fenamifos, datum „31. srpnja 2017.” zamjenjuje se datumom „31. srpnja 2018.”
in the sixth column, expiration of approval, of row 142, ethephon, the date of ‘31 July 2017’ is replaced by ‘31 July 2018’.
U šestom stupcu, prestanak odobrenja, retka 142., etefon, datum „31. srpnja 2017.” zamjenjuje se datumom „31. srpnja 2018.”
The approvals of the active substances ethephon and fenamiphos will expire on 31 July 2017.
Odobrenja aktivnih tvari etefon i fenamifos istječu 31. srpnja 2017.
Commission Implementing Regulation (EU) 2015/416
Provedbena uredba Komisije (EU) 2015/416
approving dinotefuran as an active substance for use in biocidal products for product-type 18
o odobrenju dinotefurana kao aktivne tvari za uporabu u biocidnim proizvodima za vrstu proizvoda 18
The United Kingdom received on 29 March 2012 an application, in accordance with Article 11(1) of Directive 98/8/EC of the European Parliament and of the Council [2], for the inclusion of the active substance dinotefuran in its Annex I for use in product-type 18, insecticides, acaricides and products to control other arthropods, as defined in Annex V to that Directive.
Ujedinjena Kraljevina primila je 29. ožujka 2012. zahtjev, u skladu s člankom 11. stavkom 1. Direktive 98/8/EZ Europskog parlamenta i Vijeća [2], za uvrštenje aktivne tvari dinotefurana u Prilog I. toj Direktivi za uporabu u vrsti proizvoda 18: insekticidima, akaricidima i proizvodima za suzbijanje drugih člankonožaca, kako je utvrđeno u Prilogu V. toj Direktivi.
Dinotefuran was not on the market on 14 May 2000 as an active substance of a biocidal product.
Dinotefuran 14. svibnja 2000. nije bio na tržištu kao aktivna tvar biocidnog proizvoda.
The United Kingdom submitted an assessment report, together with its recommendations, to the European Chemicals Agency on 15 October 2013 in accordance with Article 8(1) of Regulation (EU) No 528/2012.
Ujedinjena Kraljevina je 15. listopada 2013. Europskoj agenciji za kemikalije podnijela izvješće o ocjeni zajedno sa svojim preporukama, u skladu s člankom 8. stavkom 1. Uredbe (EU) br. 528/2012.
According to that opinion, biocidal products used for product-type 18 and containing dinotefuran may be expected to satisfy the requirements laid down in Article 19(1)(b) of Regulation (EU) No 528/2012, provided that certain specifications and conditions relating to its use are satisfied.
Prema tom mišljenju, može se očekivati da će biocidni proizvodi koji se upotrebljavaju u vrsti proizvoda 18 i sadržavaju dinotefuran ispunjavati zahtjeve utvrđene u članku 19. stavku 1. točki (b) Uredbe (EU) br. 528/2012, pod uvjetom da se zadovolje određene specifikacije i uvjeti koji se odnose na njegovu uporabu.
It also appears from that opinion that the characteristics of dinotefuran render it very persistent (vP) and toxic (T) in accordance with the criteria laid down in Annex XIII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council [3].
Iz mišljenja također proizlazi da je dinotefuran zbog svojih značajki vrlo postojan (vP) i otrovan (T) prema kriterijima utvrđenima u Prilogu XIII. Uredbi (EZ) br. 1907/2006 Europskog parlamenta i Vijeća [3].
Therefore, dinotefuran should be considered as a candidate for substitution pursuant to Article 10(1)(d) of Regulation (EU) No 528/2012 for the purpose of authorising products in accordance with Article 23 of that Regulation.
Stoga dinotefuran treba smatrati potencijalnom tvari za zamjenu u skladu s člankom 10. stavkom 1. točkom (d) Uredbe (EU) br. 528/2012 za potrebe odobrenja proizvoda u skladu s člankom 23. te Uredbe.
It is therefore appropriate to approve dinotefuran for use in biocidal products for product-type 18 subject to compliance with certain specifications and conditions.
Stoga je primjereno odobriti dinotefuran za uporabu u biocidnim proizvodima za vrstu proizvoda 18 podložno zadovoljenju određenih specifikacija i uvjeta.
Since the conditions of the first subparagraph of Article 90(2) of Regulation (EU) No 528/2012 are met, the provisions of that Regulation should apply.
S obzirom na to da su uvjeti iz prvog podstavka članka 90. stavka 2. Uredbe (EU) br. 528/2012 ispunjeni, odredbe te Uredbe trebale bi se primjenjivati.
Dinotefuran should be approved for a period not exceeding 7 years in accordance with Article 10(4) of that Regulation.
Dinotefuran bi trebalo odobriti za razdoblje od najviše sedam godina u skladu s člankom 10. stavkom 4. te Uredbe.
Dinotefuran shall be approved as an active substance for use in biocidal products for product-type 18, subject to the specifications and conditions set out in the Annex.
Dinotefuran se odobrava kao aktivna tvar za uporabu u biocidnim proizvodima za vrstu proizvoda 18, podložno specifikacijama i uvjetima iz Priloga.
(RS)-1-methyl-2-nitro-3-(tetrahydro-3-furylmethyl)guanidine
(RS)-1-metil-2-nitro-3-(tetrahidro-3-furilmetil)guanidin
EC No: Not available
EZ br.: Nije dostupno
CAS No: 165252-70-0
CAS br.: 165252-70-0
31 May 2022
31. svibnja 2022.
Dinotefuran is considered a candidate for substitution in accordance with Article 10(1)(d) of Regulation (EU) No 528/2012.
Dinotefuran se smatra potencijalnom tvari za zamjenu u skladu s člankom 10. stavkom 1. točkom (d) Uredbe (EU) br. 528/2012.
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance.
Pri ocjeni proizvoda posebna se pozornost posvećuje izloženosti, rizicima i učinkovitosti povezanima sa svakom uporabom na koju se odnosi zahtjev za odobrenje, a koja nije obuhvaćena procjenom rizika za aktivnu tvar na razini Unije.
For biocidal products, authorisations are subject to the following condition:
Odobrenja za biocidne proizvode podliježu sljedećem uvjetu:
For the implementation of the common principles of Annex VI to Regulation (EU) No 528/2012, the content and conclusions of assessment reports are available on the Commission website: http://ec.europa.eu/environment/chemicals/biocides/index_en.htm.
Za provedbu općih načela Priloga VI. Uredbi (EU) br. 528/2012, sadržaj i zaključci izvješća o ocjeni dostupni su na web-mjestu Komisije: http://ec.europa.eu/environment/chemicals/biocides/index_en.htm.
For industrial or professional users, safe operational procedures and appropriate organisational measures shall be established. Where exposure cannot be reduced to an acceptable level by other means, products shall be used with appropriate personal protective equipment.
za industrijske ili profesionalne korisnike moraju se utvrditi sigurni radni postupci i odgovarajuće organizacijske mjere; ako se izloženost ne može na drugi način smanjiti na prihvatljivu razinu, proizvodi se moraju koristiti uz odgovarajuću osobnu zaštitnu opremu.
Commission Implementing Regulation (EU) 2015/417
Provedbena uredba Komisije (EU) 2015/417
approving Bacillus sphaericus 2362 serotype H5a5b, strain ABTS1743 as an active substance for use in biocidal products for product-type 18
o odobrenju Bacillus sphaericus 2362, serotip H5a5b, soj ABTS 1743 kao aktivne tvari za uporabu u biocidnim proizvodima za vrstu proizvoda 18
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products [1], and in particular the third subparagraph of Article 89(1) thereof,
uzimajući u obzir Uredbu (EU) br. 528/2012 Europskog parlamenta i Vijeća od 22. svibnja 2012. o stavljanju na raspolaganje na tržištu i uporabi biocidnih proizvoda [1], a posebno njezin članak 89. stavak 1. treći podstavak,
That list includes Bacillus sphaericus.
Taj popis uključuje Bacillus sphaericus.
Bacillus sphaericus has been evaluated in accordance with Article 90(2) of Regulation (EU) No 528/2012 for use in biocidal products for product-type 18, insecticides, acaricides and products to control other arthropods, as defined in Annex V to Regulation (EU) No 528/2012.
Bacillus sphaericus ocijenjen je u skladu s člankom 90. stavkom 2. Uredbe (EU) br. 528/2012 za uporabu u biocidnim proizvodima za vrstu proizvoda 18, insekticidi, akaricidi i proizvodi za suzbijanje drugih člankonožaca, kako su definirani u Prilogu V. Uredbi (EU) br. 528/2012.
The data submitted for the purpose of the evaluation allowed conclusions to be drawn only regarding a certain form of Bacillus sphaericus, i.e. Bacillus sphaericus 2362 serotype H5a5b, strain ABTS1743.
Podaci podneseni u svrhu ocjenjivanja omogućili su donošenje zaključaka samo za određeni oblik Bacillus sphaericus, tj. Bacillus sphaericus 2362, serotip H5a5b, soj ABTS 1743.
The evaluation did not allow conclusions to be drawn regarding any other substance complying with the definition of Bacillus sphaericus in the abovementioned list of active substances in Delegated Regulation (EU) No 1062/2014.
Na temelju ocjenjivanja nisu se mogli donijeti zaključci u odnosu na bilo koju drugu tvar koja je u skladu s definicijom Bacillus sphaericus iz navedenog popisa aktivnih tvari iz Delegirane uredbe (EU) br. 1062/2014.
Therefore, only Bacillus sphaericus 2362 serotype H5a5b, strain ABTS1743 should be covered by this approval.
Stoga bi samo Bacillus sphaericus 2362, serotip H5a5b, soj ABTS 1743 trebao biti obuhvaćen ovim odobrenjem.
Italy was designated as evaluating competent authority and submitted an assessment report, together with its recommendations, to the Commission on 9 January 2009 in accordance with paragraphs 4 and 6 of Article 14 of Commission Regulation (EC) No 1451/2007 [3].
Italija je određena kao nadležno ocjenjivačko tijelo te je 9. siječnja 2009. Komisiji podnijela izvješće o ocjeni, zajedno sa svojim preporukama, u skladu s člankom 14. stavcima 4. i 6. Uredbe Komisije (EZ) br. 1451/2007 [3].
According to that opinion, biocidal products used for product-type 18 and containing Bacillus sphaericus 2362 serotype H5a5b, strain ABTS1743 may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC of the European Parliament and of the Council [4] provided that certain specifications and conditions relating to its use are satisfied.
U skladu s tim mišljenjem može se očekivati da će biocidni proizvodi koji se upotrebljavaju u vrstama proizvoda 18 i sadržavaju Bacillus sphaericus 2362, serotip H5a5b, soj ABTS 1743 ispuniti zahtjeve utvrđene u članku 5. Direktive 98/8/EZ Europskog parlamenta i Vijeća [4], pod uvjetom da se zadovolje određene specifikacije i uvjeti koji se odnose na njegovu uporabu.
It is therefore appropriate to approve Bacillus sphaericus 2362 serotype H5a5b, strain ABTS1743 for use in biocidal products for product-type 18 subject to compliance with certain specifications and conditions.
Stoga je primjereno odobriti Bacillus sphaericus 2362, serotip H5a5b, soj ABTS 1743 za uporabu u biocidnim proizvodima za vrstu proizvoda 18 podložno zadovoljenju određenih specifikacija i uvjeta.
Since the evaluations did not address nanomaterials, the approval should not cover such materials in accordance with Article 4(4) of Regulation (EU) No 528/2012.
S obzirom na to da se ocjene nisu odnosile na nanomaterijale, odobrenja ne bi trebala obuhvaćati takve materijale u skladu s člankom 4. stavkom 4. Uredbe (EU) br. 528/2012.
Bacillus sphaericus 2362 serotype H5a5b, strain ABTS1743 shall be approved as an active substance for use in biocidal products for product-type 18, subject to the specifications and conditions set out in the Annex.
Bacillus sphaericus 2362, serotip H5a5b, soj ABTS 1743 odobrava se kao aktivna tvar za uporabu u biocidnim proizvodima za vrstu proizvoda 18, podložno specifikacijama i uvjetima iz Priloga.
Bacillus sphaericus 2362 serotype H5a5b, strain ABTS1743
Bacillus sphaericus 2362, serotip H5a5b, soj ABTS 1743
For products that may lead to residues in food or feed, the need to set new or to amend existing maximum residue levels (MRLs) in accordance with Regulation (EC) No 470/2009 of the European Parliament and of the Council [3] or Regulation (EC) No 396/2005 of the European Parliament and of the Council [4] shall be verified, and any appropriate risk mitigation measures shall be taken to ensure that the applicable MRLs are not exceeded.
za proizvode čiji ostatci mogu ostati u hrani ili hrani za životinje treba provjeriti je li potrebno odrediti nove ili izmijeniti postojeće maksimalne razine ostataka (MRO-i) u skladu s Uredbom (EZ) br. 470/2009 Europskog parlamenta i Vijeća [3] ili Uredbom (EZ) br. 396/2005 Europskog parlamenta i Vijeća [4] i poduzeti sve odgovarajuće mjere za smanjenje rizika kako bi se osiguralo da se ne prekorače primjenjivi MRO-i.
For professional users, safe operational procedures and appropriate organisational measures shall be established. Where exposure cannot be reduced to an acceptable level by other means, products shall be used with appropriate personal protective equipment.
za profesionalne korisnike moraju se utvrditi sigurni radni postupci i odgovarajuće organizacijske mjere; ako se izloženost ne može na drugi način smanjiti na prihvatljivu razinu, proizvodi se moraju koristiti uz odgovarajuću osobnu zaštitnu opremu;
Commission Implementing Regulation (EU) 2015/418
Provedbena uredba Komisije (EU) 2015/418
amending Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the active substance Z-13-hexadecen-11-yn-1-yl acetate
o izmjeni Provedbene uredbe (EU) br. 540/2011 u pogledu uvjeta za odobrenje aktivne tvari Z-13-heksadeken-11-in-1-il acetat
The active substance Z-13-hexadecen-11-yn-1-yl acetate was included in Annex I to Council Directive 91/414/EEC [2] by Commission Directive 2008/127/EC [3] in accordance with the procedure provided for in Article 24b of Commission Regulation (EC) No 2229/2004 [4].
Aktivna tvar Z-13-heksadeken-11-in-1-il acetat uvrštena je u Prilog I. Direktivi Vijeća 91/414/EEZ [2] Direktivom Komisije 2008/127/EZ [3] u skladu s postupkom predviđenim člankom 24.b Uredbe Komisije (EZ) br. 2229/2004 [4].
Since the replacement of Directive 91/414/EEC by Regulation (EC) No 1107/2009, this substance is deemed to have been approved under that Regulation and is listed in Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 [5].
Od zamjene Direktive 91/414/EEZ Uredbom (EZ) br. 1107/2009 smatra se da je ta tvar odobrena u skladu s navedenom Uredbom te je uvrštena u dio A Priloga Provedbenoj uredbi Komisije (EU) br. 540/2011 [5].
In accordance with Article 25a of Regulation (EC) No 2229/2004, the European Food Safety Authority, hereinafter ‘the Authority’, presented to the Commission its view on the draft review report for Z-13-hexadecen-11-yn-1-yl acetate [6] on 18 December 2013.
U skladu s člankom 25.a Uredbe (EZ) br. 2229/2004 Europska agencija za sigurnost hrane (dalje u tekstu „Agencija”) dostavila je Komisiji 18. prosinca 2013. svoje mišljenje o nacrtu izvješća o pregledu za tvar Z-13-heksadeken-11-in-1-il acetat [6].
The Authority communicated its view on Z-13-hexadecen-11-yn-1-yl acetate to the notifier.
Agencija je svoje stajalište o toj tvari dostavila podnositelju prijave.
The Commission invited the notifier to submit comments on the draft review report for Z-13-hexadecen-11-yn-1-yl acetate.
Komisija je podnositelja prijave pozvala da dostavi primjedbe na nacrt izvješća o pregledu za tvar Z-13-heksadeken-11-in-1-il acetat.
The draft review report and the view of the Authority were reviewed by the Member States and the Commission within the Standing Committee on Plants, Animals, Food and Feed and finalised on 12 December 2014 in the format of the Commission review report for Z-13-hexadecen-11-yn-1-yl acetate.
Taj su nacrt izvješća o ocjeni i zaključak Agencije pregledale države članice i Komisija u okviru Stalnog odbora za bilje, životinje, hranu i hranu za životinje te su ga finalizirale 12. prosinca 2014. u obliku izvješća Komisije o pregledu za tvar Z-13-heksadeken-11-in-1-il acetat.
It is confirmed that the active substance Z-13-hexadecen-11-yn-1-yl acetate is to be deemed to have been approved under Regulation (EC) No 1107/2009.
Potvrđuje se da se aktivna tvar Z-13-heksadeken-11-in-1-il acetat smatra odobrenom u skladu s Uredbom (EZ) br. 1107/2009.
In accordance with Article 13(2) of Regulation (EC) No 1107/2009 in conjunction with Article 6 thereof and in the light of current scientific and technical knowledge, it is necessary to amend the conditions of approval of Z-13-hexadecen-11-yn-1-yl acetate.
U skladu s člankom 13. stavkom 2. Uredbe (EZ) br. 1107/2009 u vezi s njezinim člankom 6. te s obzirom na postojeća znanstvena i tehnička saznanja potrebno je izmijeniti uvjete za odobrenje tvari Z-13-heksadeken-11-in-1-il acetat.
In particular, it is appropriate to require further confirmatory information.
Osobito je primjereno zahtijevati dodatne potvrdne informacije.
Amendment to Implementing Regulation (EU) No 540/2011
Izmjene Provedbene uredbe (EU) br. 540/2011
Conclusion on the peer review of the pesticide risk assessment of the active substance Z-13-hexadecen-11-yn-1-yl acetate.
Zaključak o stručnom pregledu procjene rizika od pesticida s aktivnom tvari Z-13-heksadeken-11-in-1-il acetat.
In Part A of the Annex to Implementing Regulation (EU) No 540/2011, row 258 on the active substance Z-13-hexadecen-11-yn-1-yl acetate is replaced by the following:
U dijelu A Priloga Provedbenoj uredbi (EU) br. 540/2011 redak 258. o aktivnoj tvari Z-13-heksadeken-11-in-1-il acetat zamjenjuje se sljedećim:
Common Name, Identification Numbers
Uobičajen naziv, identifikacijski brojevi
Z-13-hexadecen-11-yn-1-yl acetate
Z-13-heksadeken-11-in-1-il acetat
CAS No 78617-58-0
CAS br. 78617-58-0
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Z-13-hexadecen-11-yn-1-yl acetate (SANCO/2649/2008) and in particular Appendices I and II thereof, as finalised in the Standing Committee on Plants, Animals, Food and Feed shall be taken into account.
Za provedbu jedinstvenih načela iz članka 29. stavka 6. Uredbe (EZ) br. 1107/2009 moraju se uzeti u obzir zaključci izvješća o pregledu za Z-13-heksadeken-11-in-1-il acetat (SANCO/2649/2008), a posebice dodaci I. i II., kako su finalizirani na Stalnom odboru za prehrambeni lanac i zdravlje životinja.
Conditions of use shall include, where appropriate, risk mitigation measures.
Uvjeti uporabe trebaju uključivati, prema potrebi, mjere za smanjenje rizika.
The notifier shall submit confirmatory information as regards:
Podnositelj prijave dužan je dostaviti podatke koji potvrđuju sljedeće:
the specification of the technical material, as commercially manufactured including information on any relevant impurities;
specifikaciju tehničke aktivne tvari proizvedene za tržište, uključujući podatke o svim relevantnim nečistoćama;
exposure risk assessment for operators, workers and bystanders;
ocjenu rizika od izlaganja za korisnike sredstva, radnike i druge prisutne osobe;
environmental fate and behaviour of the substance;
životni ciklus i ponašanje tvari u okolišu;
exposure risk assessment for non-target organisms.
ocjenu rizika od izlaganja za organizme koji ne pripadaju ciljanoj skupini
The notifier shall submit to the Commission, the Member States and the Authority the information set out in point (1) by 30 June 2015 and the information set out in points (2), (3) and (4) by 31 December 2016.’
Podnositelj Komisiji, državama članicama i Agenciji dostavlja informacije navedene u točki 1. do 30. lipnja 2015., a informacije navedene u točkama 2., 3. i 4. do 31. prosinca 2016.”
Commission Implementing Regulation (EU) 2015/419
Provedbena uredba Komisije (EU) 2015/419
approving tolylfluanid as an active substance for use in biocidal products for product-type 21
o odobrenju tolilfluanida kao aktivne tvari za uporabu u biocidnim proizvodima za vrstu proizvoda 21
That list includes tolylfluanid.
Na tom se popisu nalazi i tolilfluanid.
Tolylfluanid has been evaluated in accordance with Article 90(2) of Regulation (EU) No 528/2012 for use in biocidal products for product-type 21, antifouling products, as defined in Annex V to Regulation (EU) No 528/2012.
Tolilfluanid je ocijenjen u skladu s člankom 90. stavkom 2. Uredbe (EU) br. 528/2012 za uporabu u biocidnim proizvodima za vrstu proizvoda 21, proizvodi za suzbijanje obrastanja, kako su definirani u Prilogu V. Uredbi (EU) br. 528/2012.
Finland was designated as evaluating competent authority and submitted an assessment report, together with its recommendations, to the Commission on 18 September 2012 in accordance with paragraphs 4 and 6 of Article 14 of Commission Regulation (EC) No 1451/2007 [3].
Finska je određena kao nadležno ocjenjivačko tijelo te je 18. rujna 2012. Komisiji podnijela izvješće o ocjeni, zajedno sa svojim preporukama, u skladu s člankom 14. stavcima 4. i 6. Uredbe Komisije(EZ) br. 1451/2007 [3].
According to that opinion, biocidal products used for product-type 21 and containing tolylfluanid may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC of the European Parliament and of the Council [4] provided that certain specifications and conditions relating to its use are satisfied.
U skladu s tim mišljenjem može se očekivati da će biocidni proizvodi koji se upotrebljavaju u vrsti proizvoda 21 i sadržavaju tolilfluanid ispuniti zahtjeve utvrđene u članku 5. Direktive 98/8/EZ Europskog parlamenta i Vijeća [4], pod uvjetom da se zadovolje određene specifikacije i uvjeti koji se odnose na njegovu uporabu.
Nevertheless, the acceptability of the risks related to the use of antifouling products, as well as the suitability of the proposed risk mitigation measures, need to be further confirmed.
Međutim, potrebno je dodatno provjeriti prihvatljivost rizika koji se odnose na uporabu proizvoda za suzbijanje obrastanja i prikladnost predloženih mjera za smanjenje rizika.
In order to facilitate, at the time of the renewal of the approvals of existing antifouling active substances, the review and comparison of the risks and benefits of these substances as well as of the risk mitigation measures applied, the expiry date of approval of these substances should be the same.
Kako bi se u razdoblju obnavljanja odobrenja postojećih proizvoda za suzbijanje obrastanja olakšalo preispitivanje i usporedba rizika i koristi od tih tvari kao i mjera za smanjivanje rizika, datum isteka odobrenja za te tvari treba biti isti.